| Name | Title | Contact Details |
|---|---|---|
Don Berdahl |
Chief Technology Officer | Profile |
Mission Barns is a company that produces meat products without harming animals, using a combination of cultivated animal cells and plant protein.
Fort Dearborn Company is a leading supplier of high-impact decorative labels for the beverage, food, household products, nutraceutical, paint and coatings, personal care, private label/retail and spirits markets. We specialize in a variety of solutions to fit your packaging needs. Our customers benefit from seamless migration across various label types and print technologies to best match their requirements. We are committed to Customer Intimacy and providing customers with value, service and the highest quality attainable. We deliver solutions designed to meet customer`s needs and exceed their expectations every single day. Headquartered in Elk Grove, Illinois, the company has 14 operating divisions in North America.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.